Dr. Donald N N. Forthal, MD

Dr. Forthal practices at UCI Health - Orange in Orange, California, part of UC Irvine.

Dr. Forthal's NPI, 1215017363, was assigned on October 16, 2006. Dr. Forthal graduated from UC Irvine School of Medicine in 1979. Dr. Forthal holds California license 000000G44065.

Dr. Forthal's primary practice is UCI Health - Orange, at 101 City Drive South, Orange, CA 92868 in Orange County. The practice phone is (714) 456-7890.

Dr. Forthal's primary practice is UCI Health - Orange in Orange, California, part of UC Irvine. The medical group on file is UCI Health Physicians. Dmand AI also links Dr. Forthal to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Forthal practices, 2 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Forthal's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Forthal is board certified in pediatrics by the American Board of Pediatrics. Dmand AI has Dr. Forthal's licenses on file in 2 states: California and Georgia.

Dmand AI lists acute skin infection, hiv/aids, joint or bone infection and yeast infection among the conditions Dr. Forthal treats.

CMS data shows 135 Medicare services from Dr. Forthal across 6 procedure codes in 2024, for 99 Medicare patients. Medicare paid $10,042 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 99 Medicare patients who saw Dr. Forthal in 2024. The largest group is 65 to 74, with 47 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 56% are also on Medicaid. Their average risk score is 3.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Forthal's median patient age at 58, with 45% women.

In 2024, Dr. Forthal wrote 333 Medicare Part D claims for 38 patients. 34% of them were for generic drugs. CMS names the drug for 236 of them, across 12 drugs with 11 or more claims each, at $722,586 in total drug cost. In 2023, CMS named 296 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Forthal for performance year 2024, reported through an alternative payment model (APM). Dr. Forthal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Forthal as offering telehealth.

Dmand AI links 72 papers to Dr. Forthal, published from 2005 to 2024. 2015 was the busiest year, with 5. The most frequent topics are HIV-1, HIV Antibodies and Macaca mulatta. Dr. Forthal has published most often in J Virol. Dr. Forthal's most frequent co-authors are Luis M De La Maza, MD, Richard H. Haubrich, MD and Kamyar Zadeh Kalantar-Zadeh, MD.

Dmand AI links Dr. Forthal to 1 clinical trial. Conditions studied include COVID-19 and Pneumonia, Viral. Open Payments lists research payments to Dr. Forthal that name 1 trial.

CMS Open Payments shows 2 general payments to Dr. Forthal from 2 drug and device companies from 2018 to 2023. Food and beverage make up the largest share, 100% of the total. ViiV Healthcare Company paid the most, $31. It also lists 1 research payment totaling $504 in 2020, naming 1 clinical trial.

Dr. Forthal graduated from UC Irvine School of Medicine in 1979.

Dr. Forthal is in network with 13 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.